Portfolio News
Sofinnova MD Start
Maestro Surgical Robotics System by Moon Surgical, Now CE Marked
PARIS, FRANCE and SAN FRANCISCO, CA / ACCESSWIRE / April 12, 2023 / Moon Surgical, a French-American pioneer in collaborative robotics, announced today that its Maestro System is now CE Marked under the Medical Device Regulation (EU) 2017/745.
"This new milestone is a testament to our team's hard work and dedication, and attests to the effective ramp-up of our manufacturing and quality operations," said Anne Osdoit, CEO of Moon Surgical, and a Partner in Sofinnova Partners' medtech accelerator, MD Start. "With the Maestro System, we aim to empower surgeons to perform laparoscopy with greater ease, precision, and control, improving patient outcomes and enhancing the overall surgical experience."
Thus far, fifty patients in Europe have benefited from a Maestro-assisted surgery in a clinical trial led by Pr. Guy-Bernard Cadière in Brussels, Belgium.
Globally, over 18 million patients undergo soft tissue procedures annually without the advantages of robotic surgical platforms. With the Maestro System, Moon Surgical is developing a new category of surgery that enhances traditional laparoscopy. Its state-of-the-art surgical assistance platform is specifically designed to augment the precision and control of laparoscopic surgery, supporting high-volume surgeons performing procedures such as cholecystectomy and hernia repairs and more complex multi-quadrant procedures.
Moon Surgical was founded by Professor Brice Gayet, a world-renowned laparoscopic surgeon, and incubated by Sofinnova Partners MD Start in 2020; it has moved swiftly since. The company raised $31m in May 2022, and, shortly after, announced the completion of a First-in-Human study and FDA clearance for an initial version of its Maestro system, in December of 2022.
About Moon Surgical
Moon Surgical, based in Paris, France, and San Francisco, California, believes the future of the operating room lies in the hands of the empowered surgeon.
By equipping surgeons with complete control, renewed confidence, and adaptable technology to any situation, Moon Surgical strives to improve efficiency in operating rooms and provide better surgical care for patients. The minimalistic, co-manipulation Maestro System uses tomorrow's technology to deliver these vital skills to surgeons, today.
Related News
Mainstay Medical announces positive outcomes from landmark RESTORE clinical trial of ReActiv8®
Bioptimus hits $76M funding milestone and prepares to launch groundbreaking foundation model for biology
Mediar Therapeutics enters into global licensing agreement with Lilly to advance first-in-class WISP1 antibody for the treatment of idiopathic pulmonary fibrosis (IPF)
Global debut in an ASC setting at Surgeon's Point Surgery Center for Moon Surgical's Maestro System
Tenpoint Therapeutics announces positive topline data from Phase 3 pivotal study, BRIO-II, of BRIMOCHOL™ PF for the treatment of presbyopia